These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7582066)

  • 21. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y; Okada H; Saruta T; Suzuki H
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renoprotective effect of combined antihypertensive drugs.
    Del Vecchio L; Locatelli F
    J Nephrol; 2001; 14(1):7-14. PubMed ID: 11281347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC
    Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of calcium antagonists in patients with chronic renal failure.
    Rahn KH
    Pediatr Nephrol; 2005 Sep; 20(9):1208-13. PubMed ID: 15971071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy.
    Epstein M
    Ren Fail; 1996 Nov; 18(6):813-32. PubMed ID: 8948517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of renal disease: current concepts and therapeutic approaches.
    Bourgoignie JJ
    Kidney Int Suppl; 1992 May; 36():S61-5. PubMed ID: 1614070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are calcium antagonists of value in ameliorating the course of chronic renal disease?
    Luft FC; Johnston CI
    Kidney Int Suppl; 1992 May; 36():S114-8. PubMed ID: 1614061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and chronic renal failure: the use of ACE inhibitors.
    Porush JG
    Am J Kidney Dis; 1998 Jan; 31(1):177-84. PubMed ID: 9428471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists and the progression of chronic renal failure.
    Epstein M
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):171-6. PubMed ID: 9529619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?
    Maschio G
    Nephron; 1994; 67(3):257-62. PubMed ID: 7936013
    [No Abstract]   [Full Text] [Related]  

  • 37. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.
    Usami T; Nakao N; Fukuda M; Takeuchi O; Kamiya Y; Yoshida A; Kimura G
    Kidney Int; 2003 Oct; 64(4):1445-9. PubMed ID: 12969164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of calcium channel blocker and ACE inhibitor therapy on the progression of renal insufficiency.
    Zucchelli P; Zuccalà A; Borghi M; Fusaroli M; Sasdelli M; Stallone C; Sanna G; Gaggi R; Degli Esposti E; Vendramin G
    Contrib Nephrol; 1990; 81():255-63. PubMed ID: 2093506
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nephro-protective effect of calcium antagonists].
    Deray G
    Presse Med; 1999 Oct; 28(30):1667-70. PubMed ID: 10544702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease.
    ter Wee PM; De Micheli AG; Epstein M
    Arch Intern Med; 1994 Jun; 154(11):1185-202. PubMed ID: 8203987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.